PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Aug 13, 2024 · 10-Q · 44 days after period end · 0001140361-24-037067
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$8.33M | -$11.53M | -$5.82M | -$588.93K |
| EPS Diluted | -$0.23 | -$0.37 | -$0.20 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 13, 2024 · 44 d after period end
